(Q33893391)

29 July 2017

title

Atovaquone and proguanil hydrochloride followed by primaquine for treatment of Plasmodium vivax malaria in Thailand (English)

1 reference

29 July 2017

0 references

0 references

0 references

Plasmodium vivax malaria

1 reference

1 reference

Sornchai Looareesuwan

1

object named as

Looareesuwan S

1 reference

29 July 2017

2

Wilairatana P

1 reference

29 July 2017

Glanarongran R

3

1 reference

29 July 2017

Indravijit KA

4

1 reference

29 July 2017

Supeeranontha L

5

1 reference

29 July 2017

Chinnapha S

6

1 reference

29 July 2017

Scott TR

7

1 reference

29 July 2017

Chulay JD

8

1 reference

29 July 2017

publication date

1 November 1999

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

29 July 2017

published in

1 reference

29 July 2017

volume

93

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

637-640

1 reference

Survey of resistance to chloroquine by Plasmodium vivax in Indonesia

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

High dose of primaquine in primaquine resistant vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Atovaquone and proguanil for the treatment of malaria in Brazil.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Treatment of Plasmodium vivax malaria--time for a change?

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Chemotherpeutic suppression and prophylaxis in Malaria. An experimental investigation undertaken by medical research teams in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Vivax malaria resistant to chloroquine: case reports from Bombay

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Discovery of the hypnozoite and a new theory of malarial relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Treatment of primaquine-resistant Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Vivax malaria resistant to treatment and prophylaxis with chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Atovaquone plus proguanil is an effective treatment for Plasmodium ovale and P. malariae malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Atovaquone and proguanil for Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Chloroquine-resistant Plasmodium vivax in Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Chloroquine-resistant Plasmodium vivax from Indonesia

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Plasmodium vivax infections in U.S. Army troops: failure of primaquine to prevent relapse in studies from Somalia.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Clinical response and susceptibility in vitro of Plasmodium vivax to the standard regimen of chloroquine in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Development of resistance to chloroquine by Plasmodium vivax in Myanmar

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Why are primaquine and other 8-aminoquinolines particularly effective against the mature gametocytes and the hypnozoites of malaria?

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Drug resistant Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

The treatment of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Primaquine resistance in Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

A clinical trial of mefloquine in the treatment of Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990079-2

7 January 2021

10.1016/S0035-9203(99)90079-2

Identifiers

DOI

1 reference

29 July 2017

1 reference